{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:39:59Z","timestamp":1765280399559,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["2321"],"award-info":[{"award-number":["2321"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["963341"],"award-info":[{"award-number":["963341"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.mycmed.2023.101437","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T21:34:29Z","timestamp":1695936869000},"page":"101437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["In-vivo efficiency of the novel azole compounds (ATTAF-1 and ATTAF-2) against systemic candidiasis in a murine model"],"prefix":"10.1016","volume":"33","author":[{"given":"Hamed","family":"Fakhim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afsane","family":"Vaezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3569-0035","authenticated-orcid":false,"given":"Hamid","family":"Morovati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azadeh","family":"Bandegani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiana","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Emami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davood","family":"Nasiry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedeh Mahdieh","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Ahangarkani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6010-8414","authenticated-orcid":false,"given":"Hamid","family":"Badali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mycmed.2023.101437_bib0001","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","article-title":"Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program","volume":"42","author":"Hajjeh","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.mycmed.2023.101437_bib0002","article-title":"Candida species as potential nosocomial pathogens\u2013a review","volume":"15","author":"Jahagirdar","year":"2018","journal-title":"Electron J Gener Med"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101437_bib0003","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijantimicag.2013.09.005","article-title":"Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities","volume":"43","author":"Wisplinghoff","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101437_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-020-05536-z","article-title":"Clinical characteristics, risk factors and outcomes of mixed Candida albicans\/bacterial bloodstream infections","volume":"20","author":"Zhong","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.mycmed.2023.101437_bib0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mycmed.2017.02.007","article-title":"Epidemiological and mycological characteristics of candidemia in Iran: a systematic review and meta-analysis","volume":"27","author":"Vaezi","year":"2017","journal-title":"Journal de mycologie medicale"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101437_bib0006","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases\u2014estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi"},{"key":"10.1016\/j.mycmed.2023.101437_bib0007","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fmed.2020.606976","article-title":"Trends in the epidemiology of candidemia in intensive care units from 2006 to 2017: results from the Korean National Healthcare-Associated Infections Surveillance System","volume":"7","author":"Kim","year":"2020","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101437_bib0008","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/jof7040267","article-title":"Epidemiology of Candidemia: three-year results from a croatian tertiary care hospital","volume":"7","author":"Marekovi\u0107","year":"2021","journal-title":"J Fungi"},{"issue":"suppl_3","key":"10.1016\/j.mycmed.2023.101437_bib0009","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1093\/infdis\/jix131","article-title":"Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Arendrup","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mycmed.2023.101437_bib0010","article-title":"Candida bloodstream infections: changes in epidemiology and increase in drug resistance","volume":"14","author":"Kotey","year":"2021","journal-title":"Infect Dis: Res Treatm"},{"issue":"12","key":"10.1016\/j.mycmed.2023.101437_bib0011","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.mycmed.2023.101437_bib0012","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/ejhpharm-2020-002604","article-title":"Antifungal drug resistance: an update","volume":"29","author":"Denning","year":"2022","journal-title":"Eur J Hospit Pharm"},{"key":"10.1016\/j.mycmed.2023.101437_bib0013","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.3389\/fmicb.2019.02788","article-title":"Review on antifungal resistance mechanisms in the emerging pathogen Candida auris","author":"Chaabane","year":"2019","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.mycmed.2023.101437_bib0014","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.3390\/ijms23052756","article-title":"Emerging antifungal targets and strategies","volume":"23","author":"Ivanov","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.mycmed.2023.101437_bib0015","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1021\/acs.chemrev.0c00199","article-title":"Antifungal drug resistance: molecular mechanisms in Candida albicans and beyond","volume":"121","author":"Lee","year":"2020","journal-title":"Chem Rev"},{"key":"10.1016\/j.mycmed.2023.101437_bib0016","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mib.2018.02.005","article-title":"Antifungal drug resistance: evolution, mechanisms and impact","volume":"45","author":"Revie","year":"2018","journal-title":"Curr Opin Microbiol"},{"issue":"7","key":"10.1016\/j.mycmed.2023.101437_bib0017","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019752","article-title":"Mechanisms of antifungal drug resistance","volume":"5","author":"Cowen","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"10.1016\/j.mycmed.2023.101437_bib0018","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jac\/dki473","article-title":"Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?","volume":"57","author":"Charlier","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2023.101437_bib0019","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole resistance in Candida species: a current perspective","volume":"10","author":"Berkow","year":"2017","journal-title":"Infect Drug Resist"},{"issue":"6","key":"10.1016\/j.mycmed.2023.101437_bib0020","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/QCO.0000000000000411","article-title":"Emerging multidrug-resistant Candida species","volume":"30","author":"Colombo","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.mycmed.2023.101437_bib0021","first-page":"119","article-title":"Antifungal drug resistance in pathogenic fungi","volume":"36","author":"Dromer","year":"1998","journal-title":"Med Mycol"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101437_bib0022","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/vco.12601","article-title":"Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas","volume":"18","author":"Silveira","year":"2020","journal-title":"Veterin Comparat Oncol"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101437_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-6-12","article-title":"COX-2, CB2 and P2\u00d77-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord","volume":"6","author":"Yiangou","year":"2006","journal-title":"BMC Neurol"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101437_bib0024","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11030-014-9548-0","article-title":"Novel triazole alcohol antifungals derived from fluconazole: design, synthesis, and biological activity","volume":"19","author":"Hashemi","year":"2015","journal-title":"Mol Divers"},{"issue":"7","key":"10.1016\/j.mycmed.2023.101437_bib0025","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.bmc.2015.02.011","article-title":"Synthesis and biological evaluation of fluconazole analogs with triazole-modified scaffold as potent antifungal agents","volume":"23","author":"Hashemi","year":"2015","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"10.1016\/j.mycmed.2023.101437_bib0026","doi-asserted-by":"crossref","first-page":"987","DOI":"10.4155\/fmc-2017-0295","article-title":"Discovery of benzylthio analogs of fluconazole as potent antifungal agents","volume":"10","author":"Motahari","year":"2018","journal-title":"Future Med Chem"},{"key":"10.1016\/j.mycmed.2023.101437_bib0027","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fcimb.2019.00176","volume":"9","author":"Arastehfar","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101437_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-017-2916-5","article-title":"Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry","volume":"18","author":"Aslani","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"7","key":"10.1016\/j.mycmed.2023.101437_bib0029","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s10096-020-04147-5","article-title":"Expect the unexpected: Fungemia caused by uncommon Candida species in a Turkish University Hospital","volume":"40","author":"Alp","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.mycmed.2023.101437_bib0030","doi-asserted-by":"crossref","DOI":"10.5812\/archcid.106360","article-title":"Azole antifungal resistance in Candida albicans and candida glabrata isolated from vulvovaginal candidiasis patients","volume":"16","author":"Deravi","year":"2021","journal-title":"Arch Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101437_bib0031","first-page":"43","article-title":"Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina","volume":"48","author":"Theill","year":"2016","journal-title":"Rev Argent Microbiol"},{"key":"10.1016\/j.mycmed.2023.101437_bib0032","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.micpath.2018.04.026","article-title":"TLR-2, IL-10 and IL-17-mediated immunity in experimental chemotherapy murine model of systemic candidiasis; cyclophosphamides' impact and roles","volume":"119","author":"Dehghan","year":"2018","journal-title":"Microb Pathog"},{"key":"10.1016\/j.mycmed.2023.101437_bib0033","unstructured":"Council N.R. Guide for the care and use of laboratory animals. 2010."},{"key":"10.1016\/j.mycmed.2023.101437_bib0034","unstructured":"Underwood W., Anthony R. AVMA guidelines for the euthanasia of animals: 2020 edition. Retrieved on March 2020;2013(30):2020-1."},{"issue":"1","key":"10.1016\/j.mycmed.2023.101437_bib0035","first-page":"51","article-title":"First fluconazole-resistant Candida auris isolated from fungal otitis in Iran","volume":"7","author":"Taghizadeh Armaki","year":"2021","journal-title":"Curr Med Mycol"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101437_bib0036","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/myc.13053","article-title":"Epidemiological features of nosocomial candidaemia in neonates, infants and children: a multicentre study in Iran","volume":"63","author":"Ahangarkani","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2023.101437_bib0037","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ejmech.2014.02.019","article-title":"Imidazolylchromanones containing non-benzylic oxime ethers: synthesis and molecular modeling study of new azole antifungals selective against Cryptococcus gattii","volume":"76","author":"Babazadeh-Qazijahani","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.mycmed.2023.101437_bib0038","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1590\/S1517-83822014000400031","article-title":"Treatment with some anti-inflammatory drugs reduces germ tube formation in Candida albicans strains","volume":"45","author":"Rusu","year":"2014","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.mycmed.2023.101437_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.638609","article-title":"Mechanistic understanding of Candida albicans biofilm formation and approaches for its inhibition","volume":"12","author":"Atriwal","year":"2021","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.mycmed.2023.101437_bib0040","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jsps.2018.01.007","article-title":"Modulation of Cyp450, ALS1 and COX-2 signaling pathways induced by Candida albicans infection via novel antifungal agents","volume":"26","author":"Megeed","year":"2018","journal-title":"Saudi Pharmaceut J"},{"issue":"8","key":"10.1016\/j.mycmed.2023.101437_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6808a1","article-title":"Population-based active surveillance for culture-confirmed candidemia\u2014four sites, United States, 2012\u20132016","volume":"68","author":"Toda","year":"2019","journal-title":"MMWR Surveill Summ"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101437_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-020-4883-5","article-title":"Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia","volume":"20","author":"Seyoum","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.mycmed.2023.101437_bib0043","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2023.101437_bib0044","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mib.2019.05.008","article-title":"Global epidemiology of emerging Candida auris","volume":"52","author":"Rhodes","year":"2019","journal-title":"Curr Opin Microbiol"},{"issue":"2","key":"10.1016\/j.mycmed.2023.101437_bib0045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3947\/ic.2022.0008","article-title":"Candida auris: an overview of the emerging drug-resistant fungal infection","volume":"54","author":"Sanyaolu","year":"2022","journal-title":"Infect Chemother"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101437_bib0046","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/QCO.0000000000000469","article-title":"Candida auris","volume":"31","author":"Saris","year":"2018","journal-title":"Curr Opin Infect Dis"},{"issue":"10","key":"10.1016\/j.mycmed.2023.101437_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008921","article-title":"Candida auris: Epidemiology, biology, antifungal resistance, and virulence","volume":"16","author":"Du","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mycmed.2023.101437_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.fgb.2019.103243","article-title":"Candida auris and multidrug resistance: Defining the new normal","volume":"131","author":"Lockhart","year":"2019","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.mycmed.2023.101437_bib0049","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.28327.1","article-title":"Novel antifungal agents in clinical trials","volume":"10","author":"Jacobs","year":"2021","journal-title":"F1000Research"},{"issue":"8","key":"10.1016\/j.mycmed.2023.101437_bib0050","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3390\/jof8080857","article-title":"Pharmacodynamics, mechanisms of action and resistance, and spectrum of activity of new antifungal agents","volume":"8","author":"Wiederhold","year":"2022","journal-title":"J Fungi"},{"key":"10.1016\/j.mycmed.2023.101437_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.759408","article-title":"Drug resistance and novel therapeutic approaches in invasive candidiasis","volume":"11","author":"Murphy","year":"2021","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523323000811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523323000811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:23:27Z","timestamp":1761110607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523323000811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1156523323000811"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2023.101437","relation":{},"ISSN":["1156-5233"],"issn-type":[{"type":"print","value":"1156-5233"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-vivo efficiency of the novel azole compounds (ATTAF-1 and ATTAF-2) against systemic candidiasis in a murine model","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2023.101437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 SFMM. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101437"}}